General
FSD Pharma Inc. Management Wasting Company Money by Seeking to Further Delay Shareholder Meeting
Canada NewsWire TORONTO , April 5, 2021 /CNW/ – On Tuesday, March 30, 2021 , Anthony Durkacz , a
Covid
European Commission Approves mAbxience’s Bevacizumab For The Treatment Of Certain Types Of Cancer
mAbxience, a global fully-fledged biotech company, with over a decade of experience in the development, manufacture and commercialization of
Financing
Delic’s Acquisition Target, Complex Biotech Discovery Ventures Ltd., Receives First Research Orders Through Online Payment Platform
Canada NewsWire After recently launching its Advanced Analytical Testing services, CBDV successfully receives orders through their new online payment platform
Global
Orpha Labs AG Initiates Compassionate Use Program for ORL-101 in Leukocyte Adhesion Deficiency Type II (LAD-II)
First Patient to Receive ORL-101 in Israel This Week Canada NewsWire BAAR, Switzerland,Feb. 8, 2021/CNW/ — Orpha Labs AG today
